METHOD AND SYSTEM FOR PREDICTING SKIN IRRITATION INFORMATION FOR PRESCRIPTION CONTAINING RETINOL, AND ANTI-IRRITANT OR ANTI-INFLAMMATORY COMPOSITION AGAINST RETINOL, COMPRISING IRRITATION REDUCING AGENT AS ACTIVE INGREDIENT

• Main Authors: KANG, Seongsu, SHIN, Joong-Gon, JUN, Seung-Hyun, KIM, Kyunghoe, KIM, Yunkwan, LEE, Seonju, KIM, Juhyun
• Format: Patent
• Language: English; French; Korean
• Published: 25.05.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS; SPIRITS; VINEGAR; WINE

The present invention relates to a method and a system for predicting whether a prescription containing retinol will cause irritation, selecting a prescription on the basis of the prediction of whether irritation will be induced, and recommending a product matching the selected prescription. According to the present invention, a personally optimized prescription and product information may be selected and provided by predicting whether a product causes irritation, which may differ for each individual depending on the genetic information thereof, even for the same product. In addition, the present invention relates to: an anti-irritant or anti-inflammatory composition against retinol, comprising an irritation reducing agent as an active ingredient; and an information provision method for selecting a personalized irritation reducing agent for reducing irritation or inflammation caused by retinol, the method comprising a step for checking a polymorphic site of a retinol sensitivity single nucleotide polymorphism marker. La présente invention concerne une méthode et un système servant à prédire si une prescription contenant du rétinol provoquera une irritation, à sélectionner une prescription sur la base de la prédiction permettant de savoir si l'irritation sera induite, et à recommander un produit correspondant à la prescription sélectionnée. Selon la présente invention, une prescription optimisée personnellement et des informations de produits peuvent être sélectionnées et fournies en prédisant si un produit provoque une irritation, qui peut différer pour chaque individu en fonction de ses informations génétiques, même pour le même produit. De plus, la présente invention concerne : une composition anti-irritante ou anti-inflammatoire contre le rétinol, comprenant un agent de réduction de l'irritation en tant que principe actif ; et une méthode de fourniture d'informations pour sélectionner un agent de réduction de l'irritation personnalisé servant à réduire l'irritation ou l'inflammation provoquée par le rétinol, la méthode comprenant une étape de vérification d'un site polymorphe d'un marqueur de polymorphisme mononucléotidique de sensibilité au rétinol. 본 발명은 레티놀을 포함하는 처방의 자극 유무 예측, 그리고 예측된 자극 유무에 기초한 처방 선정, 선정된 처방에 매칭되는 제품 추천 방법 및 시스템에 관한 것이다. 본 발명에 따르면, 동일한 제품이더라도 개인의 유전자 정보에 따라 달라질 수 있는 자극 유무를 예측함으로써, 개인에 최적화된 처방 선정, 그리고 제품 정보를 선정하여 제공하는 것이 가능하다. 또한, 본 발명은 자극 완화제를 유효성분으로 포함하는 레티놀에 의한 항자극 또는 항염용 조성물, 및 레티놀 민감성 단일염기다형성 마커의 다형성 부위를 확인하는 단계를 포함하는 레티놀에 의한 자극 완화 또는 염증 완화를 위한 맞춤용 자극 완화제를 선택하는 정보제공방법에 관한 것이다.